Brii Biosciences Expands Therapeutic Focus to Inc

The depression space recently got a stinging FDA rebuke -but Brii thinks it can break through with improved formulations.

近日腾盛博药公司2137.HK首席战略兼财务官李安康博士与新浪财经医药就目前biotech行业的发展见解和公司未来战略定位进行了独家对话李安康先生是芝加哥大学法学院法学及美国贝勒医学院生物医药的

A chemical engineer by training, Brii's chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

新冠肺炎疫情防控：首个国产新冠特效药获批注射一次保护期超9个月

Although vaccines will remain the pandemic's sales stars, therapeutics will play an important supporting role in the fight against SARS-CoV-2.

12月10日腾盛博药首席财务官李安康博士接受了新京报贝壳财经记者的专访他不仅介绍了联合疗法的用法用量详细解释了适宜人群更独家揭秘了研发过程

近期抗感染领域特别是乙肝领域又开始吸引资本市场的注意吉利德与专注感染性疾病的Assembly Bio建立合作伙伴关系达成1亿美金的交易